NorthWest Biotherapeutics Inc (NWBO)

[pqr]

antihama your reply is well outside of my very limited subject matter expertise however it seems to me that comparing Sotorasib (a targeted treatment and application) and DC-direct FDA approval is not an apples to apples but more an apples to alligator comparison what with the complexities of the P3 trial, historical
controls, pseudo progression, limited immunological precedent, and other material confounding factors. Aside from the resources brought to bear or not.

I’d happily settle for 2x of the Sotorasib approval process (4 months).

Hopefully you’re on to something here.

Thanks for your illuminating reply. Have a great evening.